Maintenance with Carfilzomib Following Carfilzomib, Cyclophosphamide and Dexamethasone at First Relapse or Primary Refractory Multiple Myeloma (MM) on the Phase 2 Muk Five Study: Effect on Minimal Residual Disease

Details

Request a copyRequest a copy
Serval ID
serval:BIB_54DD732C6BFD
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Production externe
Title
Maintenance with Carfilzomib Following Carfilzomib, Cyclophosphamide and Dexamethasone at First Relapse or Primary Refractory Multiple Myeloma (MM) on the Phase 2 Muk Five Study: Effect on Minimal Residual Disease
Title of the conference
Blood
Author(s)
Yong Kwee, Hinsley Samantha, De Tute Ruth M, Sherratt Debbie, Brown Sarah R, Flanagan Louise, Williams Catherine, Cavenagh Jamie, Kaiser Martin, Rabin Neil K, Ramasamy Karthik, Garg Mamta, Auner Holger W., Morgan Gareth, Davies Faith E., Owen Roger G.
Publisher
American Society of Hematology
Organization
60th Annual Meeting of the American-Society-of-Hematology (ASH)
Address
San Diego, CA
ISSN
0006-4971
1528-0020
Publication state
Published
Issued date
29/11/2018
Volume
132
Number
Supplement 1
Pages
802-802
Language
english
DOI
10.1182/blood-2018-99-116426
Web of science
000454837602180
Create date
02/12/2024 16:49
Last modification date
04/12/2024 7:07
Usage data